Company Search:
Advanced Search
Sponsored Links
Syncom Formulations (India) Limited Company Snapshot
Syncom Formulations (India) Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Syncom Formulations (India) Limited with three other companies in this sector in India: Anuh Pharma Limited (2017 sales of 2.06 billion Indian Rupees [US$31.13 million] ), Lasa Supergenerics Ltd (2.00 billion Indian Rupees [US$30.15 million] ), and Sun Pharma Advanced Research Company Limited. (1.81 billion Indian Rupees [US$27.33 million] of which 100% was Pharmaceutical Research & Development).

Sales Analysis. Syncom Formulations (India) Limited reported sales of 1.85 billion Indian Rupees (US$27.91 million) for the fiscal year ending March of 2017. This represents a very small increase of 0.5% versus 2016, when the company's sales were 1.84 billion Indian Rupees. This was the fourth straight year of sales growth at Syncom Formulations (India) Limited.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Syncom Formulations (India) Limited
  Stock Performance Chart for Syncom Formulations (India) Limited
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 1.44
(Figures in Indian Rupees)
1 Week 24.1%   13 Weeks 28.6%  
4 Weeks -32.4%   52 Weeks -23.8%  
Syncom Formulations (India) Limited Key Data:
  Ticker: 524470 Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 1,848,224,245
(Year Ending Jan 2018).
Employees: N/A
  Currency: Indian Rupees Market Cap: 1,124,138,880
  Fiscal Yr Ends: March Shares Outstanding: 780,652,000
  Share Type: Ordinary Closely Held Shares: 309,548,149
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.